Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Capital Expenditures (2017 - 2025)

Sensus Healthcare (SRTS) has 9 years of Capital Expenditures data on record, last reported at $158000.0 in Q4 2025.

  • For Q4 2025, Capital Expenditures rose 153.2% year-over-year to $158000.0; the TTM value through Dec 2025 reached $196000.0, down 28.99%, while the annual FY2025 figure was $196000.0, 28.99% down from the prior year.
  • Capital Expenditures reached $158000.0 in Q4 2025 per SRTS's latest filing, up from $4000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $337000.0 in Q3 2024 and bottomed at -$297000.0 in Q4 2024.
  • Average Capital Expenditures over 5 years is $52000.0, with a median of $29000.0 recorded in 2023.
  • Peak YoY movement for Capital Expenditures: skyrocketed 2963.64% in 2024, then tumbled 98.81% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at $38000.0 in 2021, then crashed by 73.68% to $10000.0 in 2022, then grew by 10.0% to $11000.0 in 2023, then crashed by 2800.0% to -$297000.0 in 2024, then skyrocketed by 153.2% to $158000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were $158000.0 in Q4 2025, $4000.0 in Q3 2025, and $27000.0 in Q2 2025.